[go: up one dir, main page]

NO20045233L - Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse - Google Patents

Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse

Info

Publication number
NO20045233L
NO20045233L NO20045233A NO20045233A NO20045233L NO 20045233 L NO20045233 L NO 20045233L NO 20045233 A NO20045233 A NO 20045233A NO 20045233 A NO20045233 A NO 20045233A NO 20045233 L NO20045233 L NO 20045233L
Authority
NO
Norway
Prior art keywords
forms
ondansetron
processes
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO20045233A
Other languages
English (en)
Norwegian (no)
Inventor
Judith Aronhime
Szabolcs Salyi
Csaba Szabo
Sandor Molnar
Erzsebet Meszaros Sos
Tivadar Tamas
Original Assignee
Teva Gyogyszergyar Reszvenytar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Gyogyszergyar Reszvenytar filed Critical Teva Gyogyszergyar Reszvenytar
Publication of NO20045233L publication Critical patent/NO20045233L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20045233A 2002-04-30 2004-11-29 Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse NO20045233L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37639502P 2002-04-30 2002-04-30
PCT/US2003/013220 WO2003093260A1 (fr) 2002-04-30 2003-04-29 Nouvelles formes cristallines d'ondansetron, procedes de preparation correspondant, compositions pharmaceutiques contenant ces nouvelles formes et procedes de traitement de la nausee au moyen des ces nouvelles formes

Publications (1)

Publication Number Publication Date
NO20045233L true NO20045233L (no) 2005-01-28

Family

ID=29401340

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045233A NO20045233L (no) 2002-04-30 2004-11-29 Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse

Country Status (15)

Country Link
US (1) US20040019093A1 (fr)
EP (1) EP1465887A1 (fr)
JP (1) JP2005529908A (fr)
KR (1) KR20040104677A (fr)
CN (1) CN1665803A (fr)
AU (1) AU2003223763A1 (fr)
CA (1) CA2483532A1 (fr)
DE (1) DE20320528U1 (fr)
HR (1) HRP20041136A2 (fr)
IL (1) IL164905A0 (fr)
MX (1) MXPA04010845A (fr)
NO (1) NO20045233L (fr)
PL (1) PL373192A1 (fr)
WO (1) WO2003093260A1 (fr)
ZA (1) ZA200408935B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2426026A1 (fr) * 2000-10-30 2002-05-10 Judith Aronhime Nouvelles formes de cristaux et solvates de chlorhydrate d'ondansetron et leurs procedes de preparation
DE60314400T2 (de) * 2002-04-29 2008-02-07 Teva Gyogyszergyar Zartköruen Muködo Reszvenytarsasag Verfahren zur herstellung von 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-on
FI6164U1 (fi) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronmuotoja
ES2238001B1 (es) * 2004-01-21 2006-11-01 Vita Cientifica, S.L. Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
WO2005108392A2 (fr) * 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Procede de preparation de chlorhydrate dihydrate d'ondansetron ayant une granulometrie definie
TW200800954A (en) * 2006-03-16 2008-01-01 Astrazeneca Ab Novel crystal modifications
EP2248519B1 (fr) 2006-10-02 2017-12-06 Apr Applied Pharma Research S.A. Formes galéniques de film non mucoadhésifs
CN103025321A (zh) 2010-03-23 2013-04-03 生物联合制药公司 快速溶解的药物释放系统
EP2377526A1 (fr) 2010-03-23 2011-10-19 BioAlliance Pharma Systèmes d'administration de médicaments à dissolution rapide
KR102381295B1 (ko) 2013-11-15 2022-03-31 아케비아 테라퓨틱스 인코포레이티드 ｛[5-(3-클로로페닐)-3-하이드록시피리딘-2-카보닐]아미노｝아세트산의 고체형, 이의 조성물 및 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8518745D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
WO1993000074A1 (fr) * 1991-06-26 1993-01-07 Sepracor, Inc. Methodes et compositions pour le traitement des vomissements, de la nausee et d'autres troubles faisant appel a l'ondansetron optiquement pur r(+)
CA2106642C (fr) * 1992-10-14 2005-08-16 Peter Bod Derives de carbazolone et procede d'obtention
CA2150089A1 (fr) * 1994-07-08 1996-01-09 Andrew L. Itzov Mecanisme de reglage de l'angle de biseau d'une scie a onglet combinee
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
JP3533519B2 (ja) * 2000-03-09 2004-05-31 株式会社アドバンスト・ディスプレイ Ｔｆｔ基板、フィルムキャリアおよび液晶表示素子の製法
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
DE60314400T2 (de) * 2002-04-29 2008-02-07 Teva Gyogyszergyar Zartköruen Muködo Reszvenytarsasag Verfahren zur herstellung von 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-on

Also Published As

Publication number Publication date
KR20040104677A (ko) 2004-12-10
JP2005529908A (ja) 2005-10-06
MXPA04010845A (es) 2005-01-25
AU2003223763A1 (en) 2003-11-17
US20040019093A1 (en) 2004-01-29
CA2483532A1 (fr) 2003-11-13
DE20320528U1 (de) 2004-09-16
CN1665803A (zh) 2005-09-07
EP1465887A1 (fr) 2004-10-13
ZA200408935B (en) 2006-07-26
PL373192A1 (en) 2005-08-22
WO2003093260A1 (fr) 2003-11-13
IL164905A0 (en) 2005-12-18
HRP20041136A2 (en) 2005-04-30

Similar Documents

Publication Publication Date Title
NO20074558L (no) Krystallisasjon og rensing av glykopyrroniumbromid
NO20051118L (no) Fremgangsmate til fremstilling av amorfe og keramiske materialer via smeltespinning
NO20045233L (no) Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse
MEP21908A (en) Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same
MX2009004351A (es) Anticuerpos anti-htnfalfa cristalinos.
PE20050078A1 (es) Derivados de pirrolidona como inhibidores de maob
MXPA05008705A (es) Derivados de piridina como compuestos fungicidas.
UA89830C2 (ru) Кристаллическая модификация iv пираклостробина, способы ее получения, композиция для защиты растений и применение
NO20055454L (no) Smeltedigel til en innretning for a produsere en blokk av krystallinsk materiale og en fremgangsmate for a produsere denne
NO20071012L (no) Fremgangsmate for fremstilling av D-erytro-2,2-difluor-2-deoksy-1-oksoribosederivat
PL1670778T3 (pl) Przegrupowane pentanole, sposób ich wytwarzania i ich zastosowanie jako środków hamujących zapalenia
UY27410A1 (es) Formas novedosas crudas cristalinas
DK1513800T3 (da) Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
BRPI0519292A2 (pt) compostos orgÂnicos
BRPI0416672A (pt) método de produção de uma composição granular contendo lecitina e composição granular contendo lecitina
DE50312430D1 (de) Thiazol-(bi)cycloalkyl-carboxanilide
DE60217332D1 (de) Niedrigtemperaturprozess zum extrahieren der hauptkomponenten aus pflanzen
DK1831239T5 (da) Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-gamma-lacton og nøgle-mellemprodukter til denne fremgangsmåde
NO20064606L (no) Fremgangsmate for a redusere dioksininnholdet av blekejord
ATE297893T1 (de) Verfahren zur herstellung von pyrrolidonen
DE602006003204D1 (de) Reinigungsverfahren von Moxonidine
NO20092214L (no) Krystallinske former av aryl-substituerte pyrazol-amid forbindelser
MX2008000821A (es) Nuevos derivados de piperidina.
ZA200409615B (en) Method for producing specific crystalline modifications of polymorphous substances.
ATE539805T1 (de) Verfahren und vorrichtung zur reinigung von hochschmelzenden organischen rohprodukten oder verbindungsgemischen mittels fraktionierter schichtkristallisation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application